Lanean...
Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
We report a 53-year-old man diagnosed with Richter syndrome. He was heavily pretreated and was refractory to prior therapy. He received rituximab and ibrutinib, and achieved a significant response after 1 month of therapy. Our case illustrates the importance of investigation of rituximab and ibrutin...
Gorde:
| Argitaratua izan da: | Clin Case Rep |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527807/ https://ncbi.nlm.nih.gov/pubmed/26273453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.269 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|